
ACVRL1(Alk1):TGF-β受体家族成员之一,全新的抗血管生成药 …
活化素受体样激酶1(activin receptor-like kinase-1,ACVRL1/ALK1)属于TGF-β家族的I型受体(TβRI或ALK)成员之一,是丝氨酸/苏氨酸激酶受体。 ACVRL1/ALK1基因定位于12q13,含10个外显子,基因组全长约15 kb,编码ACVRL1受体蛋白。 ACVRL1是一种整合在细胞膜上的同形二聚体跨膜糖蛋白,含503个氨基酸残基,由N端胞外区、跨膜区和几乎全由丝氨酸-苏氨酸激酶区构成的胞内区三部分组成。 ACVRL1与其他I型受体在丝氨酸-苏氨酸激酶亚结构域、GS结构 …
ACVRL1 - Wikipedia
ACVRL1 is a receptor in the TGF beta signaling pathway. It is also known as activin receptor-like kinase 1, or ALK1. This gene encodes a type I cell-surface receptor for the TGF-beta superfamily of ligands.
Molecular basis of ALK1-mediated signalling by BMP9/BMP10 …
2020年4月1日 · Activin receptor-like kinase 1 (ALK1)-mediated endothelial cell signalling in response to bone morphogenetic protein 9 (BMP9) and BMP10 is of significant importance in...
ALK1 signaling in development and disease: new paradigms
In this review, we present an updated view of the mechanism of ALK1 signaling, put forth a unified hypothesis to explain the cellular missteps that lead to AVMs associated with ALK1 deficiency, and discuss emerging roles for ALK1 signaling in diseases beyond HHT.
ALK Gene - GeneCards | ALK Protein | ALK Antibody
2024年12月24日 · ALK (ALK Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with ALK include Neuroblastoma 3 and Neuroblastoma. Among its related pathways are ASP-3026-resistant ALK mutants and GPCR Pathway. Gene Ontology (GO) annotations related to this gene include identical protein binding and protein kinase activity.
激活素受体样激酶 1 (ALK-1/ACVRL1) | 重组蛋白 | MCE
ALK-1, also known as ACVRL1, is a type I receptor for TGF-β superfamily with 2 ligands, BMP9 and BMP10. ALK-1 is predominantly expressed in endothelial cells and plays a critical role in regulating angiogenesis. ALK-1 is able to bind to TGF-β1 or activins in the presence of either TβR-II or activin type II receptors, respectively.
ALK1 as an emerging target for antiangiogenic therapy of cancer
2011年6月30日 · Activin receptor-like kinase 1 (ALK1) is an EC-restricted receptor of the large TGF-β family. 1 Herein, we will review our current understanding of ALK1 signaling and the potential of ALK1 to serve as a drug target for antiangiogenic therapy for cancer.
Genome-wide RNAi screen reveals ALK1 mediates LDL uptake and …
2016年11月21日 · ALK1 binds LDL with lower affinity than LDLR and saturates only at hypercholesterolemic concentrations. ALK1 mediates uptake of LDL into endothelial cells via an unusual endocytic pathway that...
Targeting ALK1 to block LDL transcytosis and halt atherosclerosis
2023年6月2日 · Genetic deletion of, or selective monoclonal antibody binding to, activin receptor-like kinase 1 (ALK1) inhibits LDL transcytosis into the endothelium and prevents the development of...
Activin receptor-like kinase (ALK)1 is an antagonistic ... - PubMed
Activin receptor-like kinase-1 (ALK1) induces Smad1/5 phosphorylation, leading to an increase in endothelial cell proliferation and migration, while ALK5 promotes Smad2/3 activation and inhibits both processes.